Home › Funds › HARVARD MANAGEMENT CO INC › GENB
HARVARD MANAGEMENT CO INC position in GENB
GENERATE BIOMEDICINES INC · Health Care
HARVARD MANAGEMENT CO INC reported holding 1,111,100 shares of GENB (GENERATE BIOMEDICINES INC) in its Q2 2026 13F filing — a position valued at US$18.7M, representing 0.44% of its reported portfolio and ranking #17 among its reported holdings. HARVARD MANAGEMENT CO INC has disclosed GENB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How HARVARD MANAGEMENT CO INC's GENB position evolved
HARVARD MANAGEMENT CO INC first disclosed a stake in GENB in Q1 2026 at 1,111,100 shares (US$13.9M). The position peaked in Q2 2026 at 1,111,100 shares, worth US$18.7M. Across 2 filings, HARVARD MANAGEMENT CO INC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,111,100 shares valued at US$18.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.11M | $13.89M | New |
| Q2 2026 | 1.11M | $18.74M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GENB and 13F data
GENB (GENERATE BIOMEDICINES INC) is a Health Care company. 96 other funds we track also report a position in GENB — the largest reported positions include Flagship Pioneering, LLC (US$1.06B), BRAIDWELL LP (US$55.4M), ARCH Venture Management, LLC (US$32.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GENB
- Flagship Pioneering, LLC 62.67M sh · $1.06B · Q2 2026
- BRAIDWELL LP 3.28M sh · $55.40M · Q2 2026
- ARCH Venture Management, LLC 1.94M sh · $32.80M · Q2 2026
- HARBOURVEST PARTNERS LLC 1.72M sh · $29.05M · Q2 2026
- BANQUE PICTET & CIE SA 1.77M sh · $26.63M · Q3 2026
- Harvard Management Company 1.11M sh · $18.74M · Q2 2026
- NVIDIA CORP 833.33K sh · $14.06M · Q2 2026
- Davern Capital Partners, LP 824.68K sh · $13.91M · Q2 2026
More on HARVARD MANAGEMENT CO INC
FAQ
How long has HARVARD MANAGEMENT CO INC held GENB?
HARVARD MANAGEMENT CO INC has disclosed GENB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is HARVARD MANAGEMENT CO INC's current position in GENB?
As of Q2 2026, HARVARD MANAGEMENT CO INC holds 1.11M shares of GENB (GENERATE BIOMEDICINES INC), valued at $18.74M, representing 0.44% of its reported portfolio and ranking #17.
Has HARVARD MANAGEMENT CO INC been buying or selling GENB?
In the latest 13F filing (Q2 2026), HARVARD MANAGEMENT CO INC held unchanged its position in GENB. The position peaked in Q2 2026 at 1.11M shares.
Which other funds hold GENB?
Other major institutional holders of GENB include Flagship Pioneering, LLC, BRAIDWELL LP, ARCH Venture Management, LLC, among 96 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.